AEpiA’s Dr Fatima Valdes Mora is Made of Talent!
Recent Posts
Spotlight on: Melanie Eckersley-Maslin 25 November 2022
Spotlight on: Jessamy Tiffen 25 July 2022
ECR Spotlight on: Alex Woodworth 16 July 2022
Epigenetics 2022: Four weeks left for poster abstract submissions! 15 July 2022
Emma Whitelaw ECR Publication Award 30 June 2022
Epigenetics 2022 – Meet the speakers 17 June 2022
ECR Spotlight on: Kate Giles 31 May 2022
Spotlight on: Luciano Martelotto 30 May 2022
Epigenetics 2022 speakers announced 20 April 2022
Spotlight on: Hamish King 18 April 2022
ECR Spotlight on: William Schierding 6 April 2022
Spotlight on: Louise Bicknell 14 March 2022
Categories
News (57)
Opportunities (3)
Publications (7)
Spotlight on … (16)
World epi news (2)
Archived news
2022 (12)
2021 (9)
2020 (9)
2019 (1)
2018 (6)
2017 (6)
2016 (6)
2015 (17)
2014 (1)
by AEpiA| Oct 23, 2015 | News
Congratulations to Dr Fatima Valdes Mora, one of the winners in Spain’s recent Hechos de Talento (Made of Talent) competition. In winning, she becomes the face of her native country’s talent in Medicine and Science.
The Hechos de Talento campaign is an initiative organised by Clear Channel and ESIC Business and Marketing School (Spain), along with a number of media companies and communication groups. The campaign aims to raise Spain’s global reputation and image by reminding the world that the Spanish are made of talent. Dr Valdes Mora – or Fa, as she is known at the Garvan Institute in Sydney, where she leads the Histone Variants research group – is one of ten winners, and the overall winner of the Medicine and Science category. The winners were announced at an event in Fa’s home town of Madrid earlier this month and the marketing campaign begins in 2016, with Fa and the other winners appearing on billboards around the world, including Australia.
Fa completed her PhD in 2008 at Spanish National Research Council (CSIC, Spain) and moved to Australia in 2009 to join the Garvan Institute in Sydney. She is a NBCF/Cure Cancer Australia Foundation postdoctoral fellow, and receives funding from the NHMRC and the Prostate Cancer Foundation of Australia. Fa established the Histone Variants group within the Genomics and Epigenetics Division at the Garvan in 2013. The group’s focus is on the molecular mechanisms underlying histone regulated aberrant gene transcription in cancer, with particular interests in prostate cancer and endocrine resistant breast cancer.
While the Hechos de Talento campaign enhances Spain’s image, we are pleased that Fa’s win will also raise the global profile of Australian epigenetics research. We congratulate her on this wonderful accomplishment and look forward to seeing her face on billboards and buses – as well as hearing more about her cancer research developments!